SCHEDULE 13G/A

INOZYME PHARMA INC

Common stock, par value $0.0001 per share · CUSIP: 45790W108

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Rock Springs Capital Management LP

  Shares: 0.00 · Class: 0%

• Rock Springs Capital LLC

  Shares: 0.00 · Class: 0%

• Rock Springs Capital Master Fund LP

  Shares: 0.00 · Class: 0%

• Mark Bussard

  Shares: 0.00 · Class: 0%

• Kris Jenner

  Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.